Clinical Trials Logo

Graves Disease clinical trials

View clinical trials related to Graves Disease.

Filter by:

NCT ID: NCT02685514 Completed - Clinical trials for Rrelapsed Graves' Disease

A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease

HIFURGD
Start date: October 2015
Phase: N/A
Study type: Interventional

To evaluate the short-term efficiency and safety of HIFU treatment in the relapsed Graves' disease.

NCT ID: NCT02620085 Recruiting - Graves' Disease Clinical Trials

Thyroid Disease and Personality Study

TPS
Start date: July 2011
Phase: N/A
Study type: Observational

Observe the relationship between thyroid function and personality traits

NCT ID: NCT02491567 Completed - Graves Disease Clinical Trials

DNA Methylation and Autoimmune Thyroid Diseases

THYRODNA
Start date: September 2014
Phase:
Study type: Observational

Hashimoto Thyroiditis (HT) and Graves Disease (GD) are known to be caused by abnormal immune response against self cells and tissues. Epigenetics is a novel field of biology studying the mechanisms by which the environment interacts with the genotype to produce a variety of phenotypes through modifications to chromatin that do not directly alter the DNA sequence. A very limited number of epigenetic studies have been published in patients with HT and GD so far. Therefore, the purpose of this study is to analyze DNA methylation status in White Blood Cells (WBCs) within the promoter regions of genomic sites that have been previously identified as susceptibility loci or sites for autoimmune thyroid disease, such as the CD40L, FOXP3, CTLA4, PTPN22, IL2RA, FCRL3 and HLADRB1 genes.

NCT ID: NCT02384668 Completed - Graves' Disease Clinical Trials

D-vitamin And Graves' Disease; Morbidity And Relapse Reduction

DAGMAR
Start date: March 24, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of vitamin D supplementation on morbidity and risk of relapse in patients with Graves' disease.

NCT ID: NCT02376088 Completed - Graves Disease Clinical Trials

Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease

Start date: June 2011
Phase: N/A
Study type: Observational

Patients with GD often present with glucose dysregulation, which, according to most studies, is associated with islet β-cell dysfunctions, enhanced gluconeogenesis and insulin resistance (IR). Current studies focus mainly on IR, and a few that investigate islet β-cell functions show inconsistent results. This study examined the characteristics of glucose dysregulation in Chinese patients with GD, and furthermore evaluated the effects of thyroid dysfunction on islet β-cell functions and subsequently the carbohydrate metabolism.

NCT ID: NCT02373995 Not yet recruiting - Graves' Disease Clinical Trials

Role of the Microbiome in Graves' Orbitopathy

Indigo
Start date: February 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Graves' orbitopathy (GO), also known as thyroid eye disease, affects approximately 3 million people in Europe with an estimated socioeconomic burden of 6.4 billion euros per annum. GO is a complication of Graves' disease which is an autoimmune disease and the commonest cause of an overactive thyroid gland. The treatment of GO remains unsatisfactory and the majority of patients report long-term impairment of quality of life. The effects of gut derived antigens, from micro-organisms and nutrients, on the autoimmune response will be tested in the animal model by probiotic and "contra-biotic" intervention. In the Indigo interventional trial the investigators will add to the standard anti-thyroid drug treatment (ATD) a specifically designed probiotics (LAB4, Cultech Ltd., West Glamorgan, UK) to assess whether it is possible to modify the microbiome in GD patients and improve their immunological status.

NCT ID: NCT02210741 Not yet recruiting - Graves Disease Clinical Trials

Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

Start date: August 2014
Phase: N/A
Study type: Observational

Graves' disease (MIM 27500) is the leading cause of hyperthyroidism worldwide. The prevalence of Graves' disease is quite high (2.7% in women), and there is solid evidence of genetic predisposition. Despite its clinical and scientific significance, Graves' disease is still mysterious in terms of its susceptibility genes or pathophysiological mechanisms. The immune repertoire, being the sum of T and B lymphocytes in a body at any given time, is both a snapshot and a historical record of a person's immune function. Thanks to the power of next-generation sequencing (NGS), massively parallel sequencing of the B cell and T cell receptors suddenly becomes plausible, and opens a door for many creative approaches to study immune related diseases. The ultimate goal of this project is to use both the NGS deep sequencing and immune repertoire experiment to perform Graves' disease sub-group genetic fine mapping, and to identify Graves' disease-specific T cell and B cell receptors. Furthermore, using the immune repertoire approach, investigators want to study the critical epitopes of thyroid auto-antigens, and to delineate the pathophysiological steps in various disease stages and in various sub-groups. Investigators expect to solve the immune repertoire of Graves' disease of different sub-group presentations and at various disease activity stages.

NCT ID: NCT02205801 Completed - Thyroid Nodule Clinical Trials

Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy

Start date: July 2014
Phase: N/A
Study type: Interventional

We aim to study the effect of local anesthetic when used in conjunction with general anesthesia during thyroidectomy or parathyroidectomy. We hypothesize there is equivalent pain control between bilateral superficial cervical plexus block and local wound infiltration when used in conjunction with a general anesthetic.

NCT ID: NCT02203682 Recruiting - Autoimmune Diseases Clinical Trials

Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the effects of subantimicrobial dose doxycycline (50 mg/d), administered for 12 weeks, on patients with mild Thyroid-Associated Ophthalmopathy (TAO).

NCT ID: NCT02194920 Completed - Thyroid Carcinoma Clinical Trials

Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function

Start date: October 2014
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate safety and effectiveness of normal parathyroid tissue reimplantation in forearm subcutaneous tissue in case of accidental removal of parathyroid gland during thyroid surgery.